Profile data is unavailable for this security.
About the company
Medtronic plc is a global healthcare technology company. The Company develops, manufactures, and markets its medical devices and technologies to hospitals, physicians, clinicians, and patients. Its operating segments include Cardiovascular, Medical Surgical, Neuroscience and Diabetes. Cardiovascular products include pacemakers, insertable cardiac monitors, and cardiac resynchronization therapy devices. Medical Surgical products include patient care from diagnosis to recovery, with a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications. Neuroscience products include various spinal implants, bone graft substitutes, biologic products, image-guided surgery and intra-operative imaging systems. Diabetes products include insulin pumps, continuous glucose monitoring (CGM) systems, consumables, and smart insulin pen systems. It also provides PROPEL and SINUVA. The Company is focused on cardiac ablation portfolio.
- Revenue in USD (TTM)30.81bn
- Net income in USD4.32bn
- Incorporated2014
- Employees95.00k
- LocationMedtronic PLC20 On Hatch, Hatch Street LowerDUBLIN 2IrelandIRL
- Phone+353 14381700
- Websitehttps://www.medtronic.com/
More ▼
Mergers & acquisitions
| Acquired company | MDT:NYQ since announced | Transaction value |
|---|---|---|
| Cathworks Ltd | -6.95% | -- |
| Acutus Medical Inc-Left-Heart Access Portfolio | -22.49% | 87.00m |
Data delayed at least 15 minutes, as of Jan 27 2023 18:35 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter International Inc | 14.74bn | -2.38bn | 23.27bn | 60.00k | -- | 4.20 | -- | 1.58 | -4.72 | -4.72 | 29.10 | 10.98 | 0.6171 | 3.99 | 6.37 | 245,666.70 | -9.90 | 6.03 | -11.66 | 7.22 | 36.38 | 41.58 | -16.04 | 10.02 | 1.38 | 5.22 | 0.7465 | 38.31 | 9.52 | 4.70 | 16.52 | -23.70 | 0.6589 | 16.53 |
| Zimmer Biomet Holdings Inc | 7.15bn | 338.40m | 26.34bn | 19.50k | 78.10 | 2.15 | 20.19 | 3.68 | 1.61 | 1.32 | 34.08 | 58.36 | 0.3155 | 0.9301 | 5.36 | 366,805.10 | 1.50 | 1.03 | 1.69 | 1.16 | 69.79 | 71.16 | 4.74 | 3.31 | 1.05 | 7.20 | 0.3181 | 77.35 | 11.56 | 0.4339 | 400.00 | 7.13 | -1.88 | 0.00 |
| GE HealthCare Technologies Inc | 17.99bn | 1.91bn | 31.42bn | 51.00k | 16.44 | 1.87 | 12.14 | 1.75 | 4.21 | 4.24 | 39.57 | 37.08 | -- | -- | -- | 352,784.30 | -- | -- | -- | -- | 39.51 | -- | 10.88 | -- | 0.7653 | 97.25 | 0.0025 | -- | 2.45 | -- | 11.06 | -- | -- | -- |
| Resmed Inc | 3.76bn | 809.47m | 34.01bn | 8.16k | 42.21 | 9.10 | 35.31 | 9.04 | 5.50 | 5.50 | 25.58 | 25.52 | 0.6596 | 2.06 | 6.15 | 461,185.70 | 14.19 | 13.19 | 16.10 | 15.51 | 56.71 | 57.33 | 21.51 | 18.67 | 1.82 | 22.56 | 0.3251 | 40.45 | 11.93 | 11.60 | 64.26 | 17.89 | 16.90 | 4.94 |
| DexCom, Inc. | 2.79bn | 230.00m | 41.19bn | 6.30k | 199.21 | 22.58 | 107.92 | 14.75 | 0.5354 | 0.5354 | 6.71 | 4.72 | 0.5773 | 2.87 | 5.11 | 443,301.60 | 4.75 | 5.56 | 5.72 | 6.50 | 65.97 | 67.29 | 8.24 | 8.91 | 3.43 | 12.92 | 0.5266 | 0.00 | 27.08 | 33.69 | -68.66 | -- | 47.52 | -- |
| Edwards Lifesciences Corp | 5.36bn | 1.46bn | 48.35bn | 15.70k | 33.67 | 7.79 | 30.30 | 9.01 | 2.32 | 2.32 | 8.54 | 10.04 | 0.6386 | 1.51 | 8.80 | 341,643.30 | 17.37 | 15.99 | 19.56 | 18.95 | 78.93 | 75.11 | 27.20 | 23.63 | 3.00 | -- | 0.0875 | 0.00 | 19.29 | 12.04 | 82.55 | 21.42 | 8.69 | -- |
| Boston Scientific Corporation | 12.57bn | 597.00m | 66.39bn | 41.00k | 111.67 | 3.76 | 38.40 | 5.28 | 0.4151 | 0.4151 | 8.74 | 12.32 | 0.3938 | 2.31 | 7.10 | 306,512.20 | 2.04 | 3.26 | 2.32 | 4.00 | 68.89 | 69.40 | 5.19 | 8.03 | 0.9456 | 6.77 | 0.3273 | 0.00 | 19.92 | 7.23 | 956.52 | 23.20 | 1.75 | -- |
| Becton Dickinson and Co | 18.87bn | 1.55bn | 70.60bn | 77.00k | 46.33 | 2.79 | 18.71 | 3.74 | 5.38 | 5.88 | 65.72 | 89.22 | 0.3534 | 3.41 | 8.05 | 245,064.90 | 3.06 | 2.21 | 3.54 | 2.51 | 44.92 | 45.78 | 8.66 | 6.55 | 0.6295 | 6.58 | 0.3885 | 86.56 | -1.36 | 9.31 | 2.05 | 8.45 | 6.00 | -- |
| Intuitive Surgical, Inc. | 6.22bn | 1.32bn | 88.54bn | 9.79k | 68.61 | 7.97 | 68.74 | 14.23 | 3.65 | 3.65 | 17.19 | 31.45 | 0.4691 | 2.74 | 7.21 | -- | 10.14 | 12.86 | 11.46 | 14.34 | 67.44 | 68.30 | 21.61 | 27.14 | 4.13 | -- | -- | -- | 8.97 | 14.67 | -22.43 | 5.99 | -- | -- |
| Stryker Corporation | 17.95bn | 2.46bn | 95.51bn | 46.00k | 39.26 | 5.80 | 27.77 | 5.32 | 6.43 | 6.43 | 46.95 | 43.51 | 0.5119 | 1.77 | 6.06 | 390,173.90 | 7.01 | 6.73 | 8.04 | 7.95 | 63.95 | 65.57 | 13.69 | 13.16 | 1.19 | -- | 0.4366 | 42.39 | 19.21 | 8.60 | 24.70 | 3.90 | 1.39 | 11.20 |
| Medtronic PLC | 30.81bn | 4.32bn | 108.86bn | 95.00k | 25.41 | 2.10 | 15.46 | 3.53 | 3.22 | 3.22 | 23.01 | 39.00 | 0.3331 | 2.12 | 5.54 | 324,294.80 | 4.70 | 5.08 | 5.35 | 5.72 | 67.62 | 68.46 | 14.10 | 15.45 | 1.41 | 19.75 | 0.3383 | 62.61 | 5.21 | 1.30 | 43.97 | 4.58 | 1.76 | 7.94 |
| Abbott Laboratories | 43.65bn | 6.93bn | 193.66bn | 113.00k | 28.30 | -- | 19.58 | 4.44 | 3.92 | 3.92 | 24.74 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 56.15 | 57.30 | 15.88 | 13.36 | -- | 23.06 | -- | -- | 1.34 | 9.77 | -1.95 | 30.77 | -- | -- |
Data as of Jan 27 2023. Currency figures normalised to Medtronic PLC's reporting currency: US Dollar USD
31.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2022 | 118.32m | 8.90% |
| BlackRock Fund Advisorsas of 30 Sep 2022 | 69.40m | 5.22% |
| SSgA Funds Management, Inc.as of 30 Sep 2022 | 58.99m | 4.44% |
| Massachusetts Financial Services Co.as of 30 Sep 2022 | 34.13m | 2.57% |
| Wellington Management Co. LLPas of 30 Sep 2022 | 31.10m | 2.34% |
| Capital Research & Management Co. (Global Investors)as of 30 Sep 2022 | 28.78m | 2.16% |
| Geode Capital Management LLCas of 30 Sep 2022 | 26.80m | 2.02% |
| Managed Account Advisors LLCas of 30 Sep 2022 | 18.38m | 1.38% |
| JPMorgan Investment Management, Inc.as of 30 Sep 2022 | 14.71m | 1.11% |
| Lazard Asset Management LLCas of 30 Sep 2022 | 13.91m | 1.05% |
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
